Delivery Order SPE2DX15D3012-SPE2DX24F8DG3

Award Date 10/27/23
Potential Completion Date 10/30/23
Potential Value $1.3K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with a ceiling value of $1,415.70, was granted to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., by the Defense Logistics Agency (DLA). The contract covers the delivery of 4562614658 - Atomoxetine HCL 25 mg Capsule 30s, a pharmaceutical product, with an ultimate completion date of October 27, 2023. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,342.24 delivery order is for the supply of 4,563,501,236 units of Atomoxetine HCL 25 mg capsules. The order is placed under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of 4,560,986,377 units of Atomoxetine HCL 100 mg capsules. The $1,227.31 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, and has a completion date of May 19, 2023. The contract is not designated as a set-aside award. Amerisourcebergen is a major pharmaceutical distributor that holds a $999,999,999 Indefinite...
This federal contract award, identified as SPE2DB22D2005|SPE2DB24FJGX9, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $1,321.10, is for the delivery of 4,563,448,424 units of the pharmaceutical product Atomoxetine HCL 25 mg capsules. The contract has an ultimate completion date of January 26, 2024 and was awarded on January 25, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that...
This federal contract award, valued at $3,497.38, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is a delivery order under an Indefinite Delivery Contract (IDC) with a total potential value of $999,999,999.00 that runs through November 2026. The contract covers the delivery of 4,563,045,761 units of Atomoxetine HCL 100mg capsules to support the healthcare needs of military personnel, veterans, and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $4,244.48 firm fixed-price delivery order is for the supply of Atomoxetine HCL 25 mg capsules. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive...
This federal contract award, valued at $1,699.95, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distributor, for the delivery of Atomoxetine HCL 40 mg capsules. The contract has a completion date of February 13, 2024 and is a firm fixed-price delivery order. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary...
This federal contract award is for the delivery of Atomoxetine HCL 80 mg capsules to the Defense Logistics Agency (DLA) Troop Support Medical, which is a component of the U.S. Department of Defense. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distribution company. The contract is a firm fixed-price delivery order with a ceiling value of $3,287.50 and an ultimate completion date of September 19, 2023....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,504.30 delivery order is for 4,558,371,656 units of Atomoxetine HCL 40 mg capsules. The award is part of a broader Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with the DLA Troop Support Medical. This single-award IDC serves as the primary vehicle for...
The Federal Contract Award SPE2DX15D1053|SPE2DX23F6NET was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,726.32 Firm Fixed Price Delivery Order is for the supply of 4560942254 - Atomoxetine HCL 40 MG Capsule 30S. This contract is not designated with a set-aside requirement. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
  • SPE2DX15D3012
    Indefinite Delivery Contract
  • SPE2DX15D3012-SPE2DX24F8DG3
    Delivery Order

This federal contract award, with ID SPE2DX15D3012|SPE2DX24F8DG3, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,562,627,934 units of the pharmaceutical product Atomoxetine HCL 100 mg capsules, with an ultimate completion date of October 30, 2023 and a ceiling value of $1,326.76.

The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00, which Cencora, Inc. holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical supplies to support the Department of Defense's (DoD) healthcare programs globally. The contract does not have a set-aside designation, indicating it was awarded through full and open competition.

Generated 5/12/25, 10:02 AM